β‑adrenergic receptor activation promotes the proliferation of HepG2 cells via the ERK1/2/CREB pathways-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

β‑adrenergic receptor activation promotes the proliferation of HepG2 cells via the ERK1/2/CREB pathways

Published:2023-10-17 Issue:6 Volume:26 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Lin Xingcheng¹,He Jingjing¹,Liu Fuhong¹,Li Lehui¹,Sun Longhua²,Niu Liyan³,Xi Haolin⁴,Zhan Yuan⁵,Liu Xiaohua⁶,Hu Ping¹

Affiliation:

1. Institute of Translational Medicine, Nanchang University, Nanchang, Jiangxi 330001, P.R. China

2. Department of Respiratory, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China

3. Huan Kui College, Nanchang University, Nanchang, Jiangxi 330001, P.R. China

4. Queen Mary School, Nanchang University, Nanchang, Jiangxi 330001, P.R. China

5. Department of Pathology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China

6. Department of Nursing, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference40 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study;Wang;J Gastroenterol Hepatol,2020

3. Lenvatinib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma: A cost-utility analysis;Kim;Oncologist,2020

4. Hepatocellular carcinoma: Intra-arterial delivery of doxorubicin-loaded hollow gold nanospheres for photothermal ablation-chemoembolization therapy in rats;Li;Radiology,2016

5. The immunological and metabolic landscape in primary and metastatic liver cancer;Li;Nat Rev Cancer,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3